BNR
Burning Rock Biotech Limited
There isn't enough reported data to score BNR yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
BNR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Unavailable |
BNR's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
BNR PE Valuation
BNR has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
BNR Forward outlook
There aren't enough analyst estimates for BNR to show an outlook.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
BNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$9.65 | +$10.58 |
| Q1 2026 | -$8.45 | +$26.23 |
| Q4 2025 | -$7.77 | +$42.82 |
| Q3 2025 | -$17.38 | +$45.17 |
| Q2 2025 | -$20.23 | +$62.79 |
| Q1 2025 | -$34.68 | +$51.76 |
| Q4 2024 | -$50.59 | +$45.22 |
| Q3 2024 | -$62.55 | +$41.18 |
BNR has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
BNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $20.2M | -9.2% |
| Q1 2026 | $16.2M | -19% |
| Q4 2025 | $19M | +0.2% |
| Q3 2025 | $19.8M | +2.3% |
| Q2 2025 | $22.3M | +9.6% |
| Q1 2025 | $20M | +5.9% |
| Q4 2024 | $18.9M | +4.1% |
| Q3 2024 | $19.3M | +0.8% |
BNR's revenue is shrinking: $20M last quarter, down 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -5.6 points |
| Q1 2026 | -17% | -6.1 points |
| Q4 2025 | -9.5% | +56 points |
| Q3 2025 | -12% | +18 points |
| Q2 2025 | -7.7% | +74 points |
| Q1 2025 | -11% | +89 points |
| Q4 2024 | -65% | +72 points |
| Q3 2024 | -30% | +110 points |
BNR's operating margin was −13% last quarter, down 5.6 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over BNR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over BNR on profitability, with a higher operating margin.
BNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.4M | +$3.3M |
| Q1 2026 | -$4.4M | -$867K |
| Q4 2025 | $2.7M | +30% |
| Q3 2025 | $2.5M | +$7M |
| Q2 2025 | -$6.7M | -$527.2K |
| Q1 2025 | -$3.5M | +$2.5M |
| Q4 2024 | $2M | +$5.7M |
| Q3 2024 | -$4.5M | +$2.6M |
BNR has burned cash in almost every quarter: −$3M over the past year, against −$13M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over BNR on cash generation, producing positive trailing cash flow while its opponent burns cash.
BNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +34.1K shares |
| 1 year | +0.9% | +9.2K shares |
| 3 years | +6% | +61.3K shares |
| 5 years | +4.3% | +45.2K shares |
| Available history | +369% | +854K shares |
BNR has 1M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $10,805 |
| Q3 2024 | — |
BNR hasn't bought back shares in the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over BNR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
BNR Net Leverage
BNR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
BNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 34.9 | Neutral |
BNR's weekly RSI is 50 (neutral) and its Stochastic is 35 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
BNR PE vs Healthcare Sector
BNR has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
BNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 5.4% below |
| 20 week MA | $11.9 | 12% above |
| 50 week MA | $16.7 | 20% below |
| 100 week MA | $11.7 | 14% above |
| 200 week MA | $12.5 | 6.9% above |
BNR has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
BNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $246.3 | $257.5 | +4.5% |
| 2021 | $257.5 | $105.0 | -59% |
| 2022 | $105.0 | $20.8 | -80% |
| 2023 | $20.8 | $9.30 | -55% |
| 2024 | $9.30 | $7.14 | -23% |
| 2025 | $7.14 | $21.2 | +197% |
| 2026 YTD | $21.2 | $13.3 | -37% |
BNR has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.